<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Genes &amp; Cells</journal-id><journal-title-group><journal-title xml:lang="en">Genes &amp; Cells</journal-title><trans-title-group xml:lang="ru"><trans-title>Гены и Клетки</trans-title></trans-title-group><trans-title-group xml:lang="zh"><trans-title>Genes and Cells</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2313-1829</issn><issn publication-format="electronic">2500-2562</issn><publisher><publisher-name xml:lang="en">Human Stem Cells Institute</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">120720</article-id><article-id pub-id-type="doi">10.23868/201808017</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Programmed necrosis and tissue regeneration</article-title><trans-title-group xml:lang="ru"><trans-title>Программируемый некроз и регенерация тканей</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kopeina</surname><given-names>G. S</given-names></name><name xml:lang="ru"><surname>Копеина</surname><given-names>Г. С</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Zamaraev</surname><given-names>A. V</given-names></name><name xml:lang="ru"><surname>Замараев</surname><given-names>А. В</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Zhivotovsky</surname><given-names>B. D</given-names></name><name xml:lang="ru"><surname>Животовский</surname><given-names>Б. Д</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Lavrik</surname><given-names>I. N</given-names></name><name xml:lang="ru"><surname>Лаврик</surname><given-names>И. Н</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">M.V. Lomonosov Moscow State University</institution></aff><aff><institution xml:lang="ru">Московский государственный университет им. М.В. Ломоносова</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Institute of Environmental Medicine, Karolinska Institute</institution></aff><aff><institution xml:lang="ru">Институт медицины окружающей среды, Каролинский институт</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2018-06-15" publication-format="electronic"><day>15</day><month>06</month><year>2018</year></pub-date><volume>13</volume><issue>2</issue><issue-title xml:lang="en">VOL 13, NO2 (2018)</issue-title><issue-title xml:lang="ru">ТОМ 13, №2 (2018)</issue-title><fpage>35</fpage><lpage>38</lpage><history><date date-type="received" iso-8601-date="2023-01-05"><day>05</day><month>01</month><year>2023</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2018, Eco-Vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2018, Эко-Вектор</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="en">Eco-Vector</copyright-holder><copyright-holder xml:lang="ru">Эко-Вектор</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://genescells.ru/2313-1829/article/view/120720">https://genescells.ru/2313-1829/article/view/120720</self-uri><abstract xml:lang="en"><p>Programmed necrosis or necroptosis plays an important role in cell physiology. Disturbances in necroptotic process are associated with excessive cell death, the development of a number of pathological conditions, including inflammatory and neurodegenerative diseases. Accumulated evidences suggest the involvement of necroptosis in the induction of stem cell proliferation and tissue regeneration. The necrotic death can be triggered through the family of receptors of tumor necrosis factor, TRAILR1/2, FAS, as well as endosomal Toll-like and NOD-like receptors. An important role in the regulation of necroptosis belongs to proteins RIPK1 and RIPK3, which also might be essential for proliferation of stem cells and the regeneration process. Recent study has shown that necroptosis can lead to rapid activation of progenitor cells and regeneration of the hepatic tissues, as well as a necrotic-induced tissue regeneration and differentiation of c-kit+ cells in a model of myocardial infarction. Thus, the investigation of interplay between necroptosis and regeneration of damaged tissues will allow us to understand the fundamental aspects of programmed cell death and cell division.</p></abstract><trans-abstract xml:lang="ru"><p>Програмируемый некроз или некроптоз, играет существенную роль в физиологических процессах в организме. Нарушение процесса некроптоза связано с избыточной гибелью клеток, развитием ряда патологических состояний, включая воспалительные и нейродегенеративные заболевания. В последнее время появляются данные об участии некроптоза в индукции пролиферации стволовых клеток и регенерации тканей. Запуск некроптотической гибели может осуществляться через рецепторы фактора некроза опухоли, TRAILR1/2, FAS, а также через эндосомальные Toll-подобные и NOD-подобные рецепторы. Основные механизмы регуляции некроптотической гибели осуществляются на уровне главных белков - RIPK1 и RIPK3, которые способны принимать участие в пролиферации стволовых клеток и процессе регенерации. Последние работы показали, что некротические процессы могут приводить к быстрой активации клеток-предшественниц и регенерации печени, а также на модели инфаркта миокарда была продемонстрирована некроптоз-индуцированная регенерация ткани и дифференцировка c-kit+ клеток. Таким образом, изучение механизмов взаимосвязи некроптоза и регенерации поврежденных тканей позволит лучше понять фундаментальные аспекты программируемой гибели и деления клеток.</p></trans-abstract><kwd-group xml:lang="en"><kwd>necroptosis</kwd><kwd>regeneration</kwd><kwd>cell death</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>некроптоз</kwd><kwd>регенерация</kwd><kwd>гибель клеток</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Galluzzi L., Vitale I., Aaronson S.A. et al. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ. 2018; 25(3): 486-541.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Деев Р.В., Билялов А.И., Жампеисов Т.М. Современные представления о клеточной гибели. Гены и Клетки 2018; 13(1): 6-19.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Zhou W., Yuan J. Necroptosis in health and diseases. Semin. Cell Dev. Biol. 2014; 35: 14-23.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Wu W., Liu P., Li J. Necroptosis: An emerging form of programmed cell death. Crit. Rev. Oncol. Hematol. 2012; 82(3): 249-58.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Linkermann A., Green D.R. Necroptosis. N. Engl. J. Med. 2014; 370(V): 455-65.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Wilson N.S., Dixit V., Ashkenazi A. Death receptor signal transducers: nodes of coordination in immune signaling networks. Nat. Immunol. 2009; 10(4): 348-55.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Hacker H., Karin M. Regulation and Function of IKK and IKK-Related Kinases. Sci. STKE 2006; 357: re13.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Cho Y.S., Challa S., Moquin D. et al. Phosphorylation-Driven Assembly of the RIP1-RIP3 Complex Regulates Programmed Necrosis and Virus-Induced Inflammation. Cell 2009; 137(6): 1112-23.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Moriwaki K., Chan F.K. RIP3: a molecular switch for necrosis and inflammation. Genes Dev. 2013; 27: 1640-9.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Sun L., Wang H., Wang Z. et al. Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell 2012; 148: 213-27.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Murphy J.M., Czabotar P.E., Hildebrand J.M. et al. The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism. Immunity 2013; 39: 443-53.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Dondelinger Y., Declercq W., Montessuit S. et al. MLKL compromises plasma membrane integrity upon binding to phosphatidyl inositol phosphates. Cell Rep. 2014; 7: 1-11.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Feoktistova M., Geserick P., Kellert B. et al. CIAPs Block Ripoptosome Formation, a RIP1/Caspase-8 Containing Intracellular Cell Death Complex Differentially Regulated by cFLIP Isoforms. Mol. Cell 2011; 43: 449-63.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Tenev T., Bianchi K., Darding M. et al. The Ripoptosome, a Signaling Platform that Assembles in Response to Genotoxic Stress and Loss of IAPs. Mol. Cell 2011; 43: 432-48.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Feoktistova M., Geserick P., Panayotova-Dimitrova D. et al. Pick your poison: The Ripoptosome, a cell death platform regulating apoptosis and necroptosis. Cell Cycle 2012; 11: 460-7.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Craig C.E., Quaglia A., Selden C. et al. The Histopathology of Regeneration in Massive Hepatic Necrosis. Semin. Liver Dis. 2004; 24(1): 49-64.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Weng H., Cai X., Yuan X. et al. Two sides of one coin: Massive hepatic necrosis and progenitor cell-mediated regeneration in acute liver failure. Front. Physiol. 2015; doi:10.3389/fphys.2015.00178.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Wang H., Sun L., Su L. et al. Mixed Lineage Kinase Domain-like Protein MLKL Causes Necrotic Membrane Disruption upon Phosphorylation by RIP3. Mol. Cell 2014; 54: 133-46.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Ramachandran A., Mcgill M.R., Xie Y. et al. Receptor interacting protein kinase 3 is a critical early mediator of acetaminophen-induced hepatocyte necrosis in mice. Hepatology 2013; 58(6): 2099-108.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Liu J., Wu P., Wang H. et al. Necroptosis Induced by Ad-HGF Activates Endogenous C-Kit+Cardiac Stem Cells and Promotes Cardiomyocyte Proliferation and Angiogenesis in the Infarcted Aged Heart. Cell. Physiol. Biochem. 2016; 40(5): 847-60.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Habib А.А., Chatterjee S., Park S.K. et al. The epidermal growth factor receptor engages receptor interacting protein and nuclear factor-kappa B (NF-kappa B)-inducing kinase to activate NF-kappa B. Identification of a novel receptor-tyrosine kinase signalosome. J. Biol. Chem. 2001; 276(12): 8865-74.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Park S., Zhao D., Hatanpaa K.J. et al. RIP1 activates PI3K-Akt via a dual mechanism involving NF-KB-mediated inhibition of the mTOR-S6K-IRS1 negative feedback loop and down-regulation of PTEN. Cancer Res. 2009; 69(10): 4107-11.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Roderick J.E., Hermance N., Zelic M. et al. Hematopoietic RIPK1 deficiency results in bone marrow failure caused by apoptosis and RIPK3-medi-ated necroptosis. PNAS USA 2014; 111(40): 14436-41.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Moriwaki K., Balaji S., McQuade T. et al. The Necroptosis Adaptor RIPK3 Promotes Injury-Induced Cytokine Expression and Tissue Repair. Immunity 2014; 41(4): 567-78.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Moriwaki K., Balaji S., Bertin J. et al. Distinct Kinase-Independent Role of RIPK3 in CD11c+Mononuclear Phagocytes in Cytokine-Induced Tissue Repair. Cell Rep. 2017; 18(10): 2441-51.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Zamaraev A.V., Kopeina G.S., Zhivotovsky B. et al. Cell death controlling complexes and their potential therapeutic role. Cell. Mol. Life Sci. 2015; 72(3): 505-17.</mixed-citation></ref></ref-list></back></article>
